Vor Biopharma Inc. announced the resignation of two board members, Joshua Resnick, M.D., and Matthew Patterson, effective immediately. Additionally, Ms. Reed has been appointed as a new director, nominated by RA Capital as part of a prior agreement.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vor Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-189435), on August 27, 2025, and is solely responsible for the information contained therein.